Stoke Therapeutics, Inc. (STOK)

NASDAQ: STOK · Real-Time Price · USD

27.91

-0.24 (-0.85%)

At close: Sep 16, 2026, 4:00 PM EDT

27.51

-0.40 (-1.43%)

After-hours: Sep 16, 2026, 5:34 PM EDT

Stoke Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,801	1,813	584	235	364	883
Market Cap Growth	40.09%	210.31%	148.73%	-35.46%	-58.77%	-60.67%
Enterprise Value	1,449	1,489	320	23	118	652
Last Close Price	28.15	31.74	11.03	5.26	9.23	23.99

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	65.82	9.83	15.98	26.75	29.34	-
PB Ratio	5.08	5.14	2.55	1.47	1.97	4.05
P/TBV Ratio	5.25	5.14	2.55	1.47	1.97	4.05
P/FCF Ratio	-	40.36	-	-	-	-
P/OCF Ratio	-	39.77	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	53.07	8.07	8.76	2.67	9.51	-
EV/FCF Ratio	-	33.15	-	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.01	0.01	0.02	0.04	0.03	0.02
Debt / FCF Ratio	-	0.09	-	-	-	-
Net Debt / Equity Ratio	-1.02	-1.10	-1.06	-1.22	-1.22	-0.99
Net Debt / EBITDA Ratio	1.59	20.55	2.44	1.73	2.18	2.52
Net Debt / FCF Ratio	1.95	-8.61	2.78	2.35	6.27	3.15
Asset Turnover	0.07	0.54	0.15	0.04	0.05	-
Quick Ratio	7.19	5.06	5.47	6.54	7.33	12.83
Current Ratio	7.69	5.28	5.81	6.99	7.77	13.37
Return on Equity (ROE)	-61.10%	-2.37%	-45.80%	-60.80%	-50.20%	-34.06%
Return on Assets (ROA)	-35.87%	-3.73%	-25.35%	-29.62%	-26.36%	-20.04%
Return on Capital Employed (ROCE)	-63.50%	-5.70%	-43.80%	-58.10%	-46.40%	-38.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-11.45%	-0.38%	-15.23%	-44.58%	-27.77%	-9.72%
FCF Yield	-9.95%	2.48%	-14.90%	-35.20%	-9.84%	-7.72%
Buyback Yield / Dilution	-7.27%	-9.65%	-22.76%	-13.11%	-5.87%	-9.71%

SEC Filings: 10-K · 10-Q